| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/01/2009 | US20090004212 Tumour vaccines for MUC1-positive carcinomas |
| 01/01/2009 | US20090004205 Prospective identification and characterization of breast cancer stem cells |
| 01/01/2009 | US20090004199 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 01/01/2009 | US20090004198 Human monoclonal antibody binding to human cytomegalovirus and its antigen binding portion |
| 01/01/2009 | US20090004194 Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity |
| 01/01/2009 | US20090004192 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 01/01/2009 | US20090004191 Expansion of Stem/Progenitor Cells by Inhibition of Enzymatic Reactions Catalyzed by the Sir2 Family of Enzymes |
| 01/01/2009 | US20090004186 Effector function enhanced recombinant antibody composition |
| 01/01/2009 | US20090004183 Compositions and Methods for Regulating the Alternative Pathway of Complement |
| 01/01/2009 | US20090004163 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells |
| 01/01/2009 | US20090004162 Hecgf-1 Related Polymorphisms and Applications Thereof |
| 01/01/2009 | US20090004160 Mass Producing Method of Growth Factor Using Adipose Derived Adult Stem Cells |
| 01/01/2009 | US20090004159 Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells |
| 01/01/2009 | US20090004158 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 01/01/2009 | US20090004157 Mature type-1 polarized dendritic cells with enhanced il-12 production and methods of serum-free production and use |
| 01/01/2009 | US20090004156 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE |
| 01/01/2009 | US20090004153 Muscle derived cells for the treatment of urinary tract pathologies and methods of making and using same |
| 01/01/2009 | US20090004152 Exposing embryonic stem cells culture to cells expressing activin receptor-like kinase (ALK) receptor, transplanting tissues into mammal, recovering insulin secreting cells; endocrine cell therapy |
| 01/01/2009 | US20090004151 Method of Three-Dimesionally Culturing Chondrocytes |
| 01/01/2009 | US20090004150 Method for Expanding Postembryonic Stem and Progenitor Cells from Umbilical Cord Blood and Immunotherapeutic Agent |
| 01/01/2009 | US20090004142 A cell therapy method for the treatment of tumors |
| 01/01/2009 | US20090004118 Multifunctional Nanoparticle Conjugates And Their Use |
| 01/01/2009 | US20090004112 Methods for the treatment of neurodegenerative diseases using nmda receptor glycine site antagonists |
| 01/01/2009 | US20090004109 Antibodies and Molecules Derived Therefrom that Bind to Steap-1 Proteins |
| 01/01/2009 | US20090004103 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 12/31/2008 | WO2009002811A2 Therapeutic platelet compositions and methods |
| 12/31/2008 | WO2009002559A1 Neural stem cells |
| 12/31/2008 | WO2009002515A1 Th-17 cells |
| 12/31/2008 | WO2009002456A2 Methods and compositions relating to progenitor cells |
| 12/31/2008 | WO2009002223A1 Method for producing a human hybrid stem cell |
| 12/31/2008 | WO2009001851A1 Additive for in vitro maturation culture of mammalian immature ovum, and method for production of mature ovum using the same |
| 12/31/2008 | WO2009001555A1 Expression controller of type i interferon |
| 12/31/2008 | WO2009001392A1 Gene codifying for ambra 1 protein which regulates autophagv and the development of the central nervous system |
| 12/31/2008 | WO2009000894A1 Anti-vpac1 antibodies and their uses |
| 12/31/2008 | WO2009000555A1 Method of generating glucose-responsive cells |
| 12/31/2008 | WO2009000539A1 Modulation of production of retroviruses by apobec4 |
| 12/31/2008 | WO2009000347A1 Isolated proliferating cells with stem cell properties from adult tissue of poikilothermic vertebrates, stable cell cultures thereof, and method for their preparation |
| 12/31/2008 | WO2008138131B1 Bone targeted alkaline phosphatase, kits and methods of use thereof |
| 12/31/2008 | WO2008138131A4 Bone targeted alkaline phosphatase, kits and methods of use thereof |
| 12/31/2008 | WO2008137629A3 Identifying germline competent embryonic stem cells |
| 12/31/2008 | WO2008135837A3 Method and device for non- invasive prenatal diagnosis |
| 12/31/2008 | WO2008134640A3 Cells expressing chimeric ns4a proteins of hcv and their use in assays |
| 12/31/2008 | WO2008110868A3 Proliferated islets |
| 12/31/2008 | WO2008081457A3 Methods of isolating cardiac stem cells, banking and uses thereof |
| 12/31/2008 | WO2008064094A3 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof |
| 12/31/2008 | WO2008060792A3 Novel cells, compositions, and methods |
| 12/31/2008 | WO2007140246A3 Methods and compositions for increasing biomass in genetically modified perennials used for biofuel |
| 12/31/2008 | WO2007138119A8 Procedure for the preparation of unilamellar vesicles for cryopreservation and the culture of stem cells and embryos |
| 12/31/2008 | WO2007106200A3 Expansion and differentiation of neural stem cells under low oxygen conditions |
| 12/31/2008 | WO2007075933A3 Translocation and mutant csf1r kinase in human leukemia |
| 12/31/2008 | WO2006111960A3 Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent |
| 12/31/2008 | EP2009109A1 G protein-related kinase mutants in essential hypertension |
| 12/31/2008 | EP2009104A1 Phosphorylation epitopes of Tau protein for the diagnosis and treatment of Alzheimer's disease |
| 12/31/2008 | EP2009101A1 Antibody modification method for purifying bispecific antibody |
| 12/31/2008 | EP2009097A1 Normal prostate stem cells |
| 12/31/2008 | EP2009096A2 Biotransplant for cellular therapy based on mesenchymal bone marrow stem cells |
| 12/31/2008 | EP2009095A1 Method of generating glucose-responsive cells |
| 12/31/2008 | EP2009094A1 Fusion partner cells |
| 12/31/2008 | EP2009026A1 Anti-VPAC1 antibodies and their uses |
| 12/31/2008 | EP2009021A1 DNA molecules encoding ligand gated ion channels from dermacentor variabilis |
| 12/31/2008 | EP2009019A1 P53 binding T cell receptor molecules and uses thereof |
| 12/31/2008 | EP2008664A2 Modified proteins which bind extracellular matrix components |
| 12/31/2008 | EP2007906A2 Use of glis3 for preparing functional pancreatic beta-cells |
| 12/31/2008 | EP2007899A2 Antibodies directed to angiopoietin-like protein 4 and uses thereof |
| 12/31/2008 | EP2007881A2 Tissue engineering with human embryonic stem cells |
| 12/31/2008 | EP2007880A2 Survival and development of neural cells |
| 12/31/2008 | EP2007879A2 Cell co-culture |
| 12/31/2008 | EP2007878A2 Automatable artificial immune system (ais) |
| 12/31/2008 | EP2007877A2 Methods for compact aggregation of dermal cells |
| 12/31/2008 | EP2007876A2 Three dimensional cell culture |
| 12/31/2008 | EP2007875A2 Dermis-derived cells for tissue engineering applications |
| 12/31/2008 | EP2007874A2 Propagation of primary cells |
| 12/31/2008 | EP2007815A2 Mono- and bifunctional molecules with ability to bind to g protein-coupled receptors |
| 12/31/2008 | EP2007424A2 Tumor cell differentiation agents as chemical inhibitors and treatments for intracellular parasites |
| 12/31/2008 | EP2007411A2 Regulating stem cells |
| 12/31/2008 | EP2007312A2 A shape-based approach for scaffoldless tissue engineering |
| 12/31/2008 | EP1948787A4 Composition comprising okadaic acid for undifferentiated proliferation of embryonic stem cells |
| 12/31/2008 | EP1907530A4 Compositions and methods for treating tissue |
| 12/31/2008 | EP1869165A4 Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase |
| 12/31/2008 | EP1824967A4 Recombinant dna constructs and methods for controlling gene expression |
| 12/31/2008 | EP1792986B1 Novel carbonyl reductase, gene thereof and method of using the same |
| 12/31/2008 | EP1773872A4 Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof |
| 12/31/2008 | EP1750773B1 Drugs for the prevention or treatment of immunodeficiencies, autoimmune diseases or for the induction of immune tolerance |
| 12/31/2008 | EP1678193B1 Hepatocellular carcinoma specific promoter and uses thereof |
| 12/31/2008 | EP1660536B1 FACTOR IXa SPECIFIC ANTIBODIES DISPLAYING FACTOR VIIIa LIKE ACTIVITY |
| 12/31/2008 | EP1551976B1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 12/31/2008 | EP1512744B1 Pigment protein |
| 12/31/2008 | EP1412503B1 A fusion protein |
| 12/31/2008 | EP1371732B1 Fused protein having beta 1,2-n-acetylglucosaminyltransferase ii activity and process for producing the same |
| 12/31/2008 | EP1367961B1 Peptide scaffold encapsulation of tissue cells and uses thereof |
| 12/31/2008 | EP1356111B1 Nucleus export reporter system |
| 12/31/2008 | EP1350085B1 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc) |
| 12/31/2008 | EP1294879B1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 12/31/2008 | EP1272527B1 Preparation of antibodies having adcc via cd16, such as anti-rhesus d monoclonal antibodies |
| 12/31/2008 | EP1268761B1 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof |
| 12/31/2008 | EP1255850B1 Amplification of cyp24 and uses thereof |
| 12/31/2008 | EP1251731B1 Protein kinase stress-related proteins and methods of use in plants |
| 12/31/2008 | EP1239042B1 Transposase and method of gene modification |
| 12/31/2008 | EP1235073B1 cGMP-VISUALIZING PROBE AND METHOD OF DETECTING AND QUANTIFYING cGMP BY USING THE SAME |
| 12/31/2008 | EP1220952B1 Converting diploidy to haploidy for genetic diagnosis |